Page 3 - European Urology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from European urology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In European Urology Today - Breaking & Trending Today

Immunotherapy-TKI Combo More Effective for Intermediate-Risk RCC

Survival differed among real-world patients with intermediate-risk and poor-risk RCC treated with firstline immunotherapy-TKI combos. ....

Javier Molina Cerrillo , International Metastatic Renal Cell Carcinoma Database Consortium , Hospital Ram , European Urology ,

ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

British Columbia , United Kingdom , United States , Andrea Maddox Smith , Jonathan Suderman , Aashish Kamat , Peter Black , Roger Buckley , Sams Chang , Karim Chamie , University Of British Columbia , Immunitybio Inc , Immunitybio Patient Assistance Program , Bladder Cancer Advocacy Network , Exchange Commission , Drug Administration , Company Form , American Cancer Society , Vanderbilt Ingram Cancer Center , American Urological Association , Patient Assistance Program , Bacillus Calmette Gu , Business Wire , Patrick Soon Shiong , Executive Chairman , Global Chief Scientific ,

European Urology Names Fox Chase Cancer Center's Dr. Andres F. Correa Reviewer of the Month

The journal European Urology has named Fox Chase Cancer Center urologic oncologist Andres F. Correa, MD, its March 2024 Reviewer of the Month. ....

United States , Fox Chase Cancer Center , Fox Chase , Andresf Correa , Alexander Kutikov , University Of Maryland School Medicine , American Urological Association , Society Of Urologic Oncology , Society Of Urologic Oncology Fellowship Director , National Hispanic Medical Association , University Of Pittsburgh Medical Center , Department Of Urology , American Medical Association , European Urology , Assistant Professor , Urologic Oncology , Urologic Oncology Fellow , Maryland School , Pittsburgh Medical Center , Chase Urologic Oncology , Clinical Oncology , Top Doctor , Press Release ,

Prostate cancer screening must be done every 5 years: Study

A simple blood test that checks for prostate-specific antigen (PSA), a marker for prostate cancer, is safe and sufficient, if done at intervals of every five years, finds a study on Saturday. ....

New Delhi , France General , Peter Albers , Heinrich Heine University , Lancet Commission On , European Association Of Urology , Department Of Urology , European Association , Lancet Commission , European Urology , Professor Peter Albers ,

Prostate cancer screening must be done every 5-years: Study

Prostate cancer screening has long been contentious. While the PSA test is useful for assessing risk, it's notorious for false positives prompting unnecessary invasive treatments and false negatives resulting in undetected cancers ....

France General , New Delhi , Peter Albers , Department Of Urology , European Association Of Urology , Lancet Commission On , Heinrich Heine University , European Association , Lancet Commission , European Urology , Professor Peter Albers , Heinrich Heine University , Prostate Cancer , Rostate Specific Antigen Psa ,